Protective effect of citronellol in rhabdomyolysis-induced acute kidney injury in mice

J Med Life. 2023 Jul;16(7):1057-1061. doi: 10.25122/jml-2023-0102.

Abstract

Acute kidney injury (AKI) is a serious pathophysiological event consequent to rhabdomyolysis. Inflammatory mechanisms play a role in the development of rhabdomyolysis-induced AKI. Citronellol (CT) is a naturally occurring monoterpene in essential oils of aromatic plant species. In this study, we explored the protective effects of citronellol on AKI resulting from glycerol-induced rhabdomyolysis. Rhabdomyolysis was induced by a single intramuscular injection of glycerol 50% (10mg/kg) in the thigh caudal muscle. Four groups of mice were assigned, including a control group, a group administered with glycerol to induce AKI as a model, a group treated with glycerol plus 50mg/kg CT, and a group treated with glycerol plus 100mg/kg CT. The renal function of mice from all groups was evaluated using kidney histopathological changes and kidney injury molecule-1 (KIM-1). Myoglobin levels were measured to detect rhabdomyolysis. Apoptosis was evaluated by renal cleaved caspase-3 and BAX levels. Both doses of citronellol (50mg/kg and 100mg/kg) significantly reduced KIM-1 mRNA expression and myoglobin levels compared to the glycerol group. In addition, citronellol resulted in lower cleaved caspase-3 and BAX in the renal tissue, indicating that citronellol exerted an anti-apoptotic effect in AKI. Citronellol showed a reno-protective effect against rhabdomyolysis-induced AKI, which may be attributed to its anti-apoptotic effects.

Keywords: AKI; BAX; Cleaved caspase-3; Rhabdomyolysis; anti-apoptotic effects.

MeSH terms

  • Acute Kidney Injury* / drug therapy
  • Acute Kidney Injury* / etiology
  • Acute Kidney Injury* / prevention & control
  • Animals
  • Apoptosis
  • Caspase 3 / pharmacology
  • Caspase 3 / therapeutic use
  • Glycerol / adverse effects
  • Kidney
  • Mice
  • Myoglobin / adverse effects
  • Rhabdomyolysis* / chemically induced
  • Rhabdomyolysis* / complications
  • Rhabdomyolysis* / drug therapy
  • bcl-2-Associated X Protein / pharmacology
  • bcl-2-Associated X Protein / therapeutic use

Substances

  • Glycerol
  • citronellol
  • Caspase 3
  • Myoglobin
  • bcl-2-Associated X Protein